Ljubljana Covid clinic suspends use of antibody treatment
Ljubljana, 6 January - Slovenia's main Covid treatment facility will suspend the use of monoclonal antibody treatment because it proved to be inefficient against Omicron, the head of the UKC Ljubljana Department of Infectious Diseases, Tatjana Lejko Zupanc, told the STA on Thursday.
The rest of this news item is available to subscribers.
The news item consists of 635 characters (without spaces) or 118 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.